High frequency of mitochondrial complex I mutations in Parkinson’s disease and aging
暂无分享,去创建一个
[1] N. Hattori,et al. Genotype in the 24-kDa subunit gene (NDUFV2) of mitochondrial complex I and susceptibility to Parkinson disease. , 1998, Genomics.
[2] R. Swerdlow,et al. Matrilineal inheritance of complex I dysfunction in a multigenerational Parkinson's disease family , 1998, Annals of neurology.
[3] H. Yoshino,et al. Mitochondrial complex I and II activities of lymphocytes and platelets in Parkinson's disease , 1992, Journal of neural transmission. Parkinson's disease and dementia section.
[4] K K Kidd,et al. Modeling of heteroduplex formation during PCR from mixtures of DNA templates. , 1992, PCR methods and applications.
[5] M. Graeber,et al. Novel mutations of mitochondrial complex I in pathologically proven Parkinson disease , 1998, Neurogenetics.
[6] K. Ohno,et al. Distinct clustering of point mutations in mitochondrial DNA among patients with mitochondrial encephalomyopathies and with Parkinson's disease. , 1991, Biochemical and biophysical research communications.
[7] C. Fall,et al. Elevated reactive oxygen species and antioxidant enzyme activities in animal and cellular models of Parkinson's disease. , 1997, Biochimica et biophysica acta.
[8] I. Nelson,et al. The mitochondrial DNA G13513A transition in ND5 is associated with a LHON/MELAS overlap syndrome and may be a frequent cause of MELAS , 1999, Annals of neurology.
[9] Todd B. Sherer,et al. Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.
[10] I. D. de Coo,et al. A 4–base pair deletion in the mitochondrial cytochrome b gene associated with parkinsonism/MELAS overlap syndrome , 1999, Annals of neurology.
[11] D. Middleton,et al. mt4216C variant in linkage with the mtDNA TJ cluster may confer a susceptibility to mitochondrial dysfunction resulting in an increased risk of Parkinson's disease in the Irish , 2003, Experimental Gerontology.
[12] Noriyuki Fuku,et al. Golden mean to longevity: Rareness of mitochondrial cytochrome b variants in centenarians but not in patients with Parkinson's disease , 2002, Journal of neuroscience research.
[13] Steven Henikoff,et al. SIFT: predicting amino acid changes that affect protein function , 2003, Nucleic Acids Res..
[14] K. Ohno,et al. Increase of deleted mitochondrial DNA in the striatum in Parkinson's disease and senescence. , 1990, Biochemical and biophysical research communications.
[15] S. Dimauro,et al. Apparent mtDNA heteroplasmy in Alzheimer's disease patients and in normals due to PCR amplification of nucleus-embedded mtDNA pseudogenes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[16] H. Checkoway,et al. Mitochondrial ND1 sequence analysis and association of the T4216C mutation with Parkinson's disease. , 2000, Neurotoxicology.
[17] M. Beal,et al. Cytochemical Demonstration of Oxidative Damage in Alzheimer Disease by Immunochemical Enhancement of the Carbonyl Reaction with 2,4-Dinitrophenylhydrazine , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[18] T. Montine,et al. Mitochondrial DNA Deletions/Rearrangements in Parkinson Disease and Related Neurodegenerative Disorders , 2002, Journal of neuropathology and experimental neurology.
[19] D. Wallace,et al. Association of mitochondrial DNA damage with aging and coronary atherosclerotic heart disease. , 1992, Mutation research.
[20] J. Braman,et al. PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases. , 1996, Nucleic acids research.
[21] D. Turnbull,et al. Respiratory chain abnormalities in skeletal muscle from patients with Parkinson's disease , 1991, Journal of the Neurological Sciences.
[22] Robert E. Davis,et al. Altered Calcium Homeostasis in Cells Transformed by Mitochondria from Individuals with Parkinson's Disease , 1997, Journal of neurochemistry.
[23] P. Modrich,et al. DNA mismatch correction in a defined system. , 1989, Science.
[24] K. Ohno,et al. Quantitative determination of deleted mitochondrial DNA relative to normal DNA in parkinsonian striatum by a kinetic PCR analysis. , 1990, Biochemical and biophysical research communications.
[25] J. Smeitink,et al. Respiratory chain complex I deficiency. , 2001, American journal of medical genetics.
[26] R. Swerdlow,et al. Abnormal Mitochondrial Morphology in Sporadic Parkinson's and Alzheimer's Disease Cybrid Cell Lines , 2000, Experimental Neurology.
[27] M. Suter,et al. Fragmented mitochondrial DNA is the predominant carrier of oxidized DNA bases. , 1999, Biochemistry.
[28] H. Reichmann,et al. Novel mitochondrial DNA mutations in Parkinson's disease , 2002, Journal of Neural Transmission.
[29] S. Dimauro,et al. A novel mitochondrial 12SrRNA point mutation in parkinsonism, deafness, and neuropathy , 2000, Annals of neurology.
[30] W. Fang,et al. Methyl-directed Repair of Mismatched Small Heterologous Sequences in Cell Extracts from Escherichia coli * , 1997, The Journal of Biological Chemistry.
[31] W. Parker,et al. Parkinson's disease transgenic mitochondrial cybrids generate Lewy inclusion bodies , 2004, Journal of neurochemistry.
[32] W. Nicklas,et al. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. , 1985, Life sciences.
[33] G. Wooten,et al. Maternal inheritance in Parkinson's disease , 1997, Annals of neurology.
[34] M. Beal,et al. Marked changes in mitochondrial DNA deletion levels in Alzheimer brains. , 1994, Genomics.
[35] C. Marsden,et al. Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease. , 1992, Brain : a journal of neurology.
[36] B. Ames,et al. Oxidants, antioxidants, and the degenerative diseases of aging. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[37] T. Montine,et al. The mitochondrial common deletion in Parkinson's disease and related movement disorders. , 2002, Parkinsonism & related disorders.
[38] Xuhua Xia,et al. Protein structure, neighbor effect, and a new index of amino acid dissimilarities. , 2002, Molecular biology and evolution.
[39] C. Marsden,et al. Mitochondrial Complex I Deficiency in Parkinson's Disease , 1990, Lancet.
[40] K. Marder,et al. Mitochondrial DNA mutations in complex I and tRNA genes in Parkinson’s disease , 2000, Neurology.
[41] S. Dimauro,et al. Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS. , 1997, Biochemical and biophysical research communications.
[42] K. Jellinger,et al. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. , 1991, Molecular and chemical neuropathology.
[43] M. Beal,et al. High aggregate burden of somatic mtDNA point mutations in aging and Alzheimer's disease brain. , 2002, Human molecular genetics.
[44] M. Beal,et al. Sequence analysis of the entire mitochondrial genome in Parkinson's disease. , 2002, Biochemical and biophysical research communications.
[45] T. Chase,et al. No evidence for altered muscle mitochondrial function in Parkinson's disease. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[46] N Howell,et al. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[47] M. Radman,et al. Methyl-directed repair of frameshift mutations in heteroduplex DNA. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[48] Masashi Tanaka. Mitochondrial genotypes and cytochrome b variants associated with longevity or Parkinson's disease , 2002, Journal of Neurology.
[49] A. Bhagwat,et al. Cooperation and competition in mismatch repair: very short‐patch repair and methyl‐directed mismatch repair in Escherichia coli , 2002, Molecular microbiology.
[50] Gary E. Gibson,et al. Low mutational burden of individual acquired mitochondrial DNA mutations in brain. , 2001, Genomics.
[51] J. Parks,et al. Abnormalities of the electron transport chain in idiopathic parkinson's disease , 1989, Annals of neurology.
[52] P. Modrich,et al. Methyl-directed DNA mismatch correction. , 1989, The Journal of biological chemistry.
[53] D. Turnbull,et al. Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA , 1999, Nature Genetics.
[54] R. Swerdlow,et al. Origin and functional consequences of the complex I defect in Parkinson's disease , 1996, Annals of neurology.
[55] J. Cooper,et al. Mitochondrial DNA transmission of the mitochondrial defect in Parkinson's disease , 1998, Annals of neurology.
[56] C. Filley,et al. Reduced platelet cytochrome c oxidase activity in Alzheimer's disease , 1994, Neurology.
[57] Phillip Nagley,et al. Precise determination of mitochondrial DNA copy number in human skeletal and cardiac muscle by a PCR-based assay: lack of change of copy number with age. , 2003, Nucleic acids research.
[58] M. Polz,et al. Heteroduplexes in mixed-template amplifications: formation, consequence and elimination by 'reconditioning PCR'. , 2002, Nucleic acids research.
[59] Dominic Thyagarajan,et al. Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease , 2003, Annals of neurology.
[60] M. Jensen,et al. Effect of PCR conditions on the formation of heteroduplex and single-stranded DNA products in the amplification of bacterial ribosomal DNA spacer regions. , 1993, PCR methods and applications.
[61] Margaret A. Johnson,et al. Role of mitochondrial DNA mutations in human aging: Implications for the central nervous system and muscle , 1998, Annals of neurology.
[62] C. Marín,et al. Mitochondria1 respiratory chain activity in skeletal muscle from patients with Parkinson's disease , 1993, Neurology.
[63] Jean-Pierre Mazat,et al. Mitochondrial threshold effects. , 2003, The Biochemical journal.
[64] D. Turnbull,et al. Accumulation of mitochondrial DNA mutations in ageing, cancer, and mitochondrial disease: is there a common mechanism? , 2002, The Lancet.
[65] C. Marsden,et al. Mitochondrial function in Parkinson's disease , 1992, Annals of neurology.
[66] O. Blin,et al. Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy , 1994, Journal of the Neurological Sciences.
[67] M. Graeber,et al. Parkinson disease: analysis of mitochondrial DNA in monozygotic twins , 2000, Neurogenetics.
[68] Robert Hill,et al. Low platelet mitochondrial complex I and complex II/III activity in early untreated parkinson's disease , 1995, Annals of neurology.
[69] R. Benecke,et al. Electron transfer complexes I and IV of platelets are abnormal in Parkinson's disease but normal in Parkinson-plus syndromes. , 1993, Brain : a journal of neurology.
[70] P. Modrich. DNA mismatch correction. , 1987, Annual review of biochemistry.
[71] D. Murdock,et al. Ancient mtDNA sequences in the human nuclear genome: a potential source of errors in identifying pathogenic mutations. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[72] M. Graeber,et al. Two novel point mutations of mitochondrial tRNA genes in histologically confirmed Parkinson disease , 1999, Neurogenetics.
[73] T. Ozawa,et al. Point mutations of mitochondrial genome in Parkinson's disease. , 1995, Brain research. Molecular brain research.
[74] R. Rosenberg. The Molecular and Genetic Basis of Neurological Disease , 1997 .
[75] Y. Kagawa,et al. Deficiencies in complex I subunits of the respiratory chain in Parkinson's disease. , 1989, Biochemical and biophysical research communications.
[76] B. Crain,et al. Mitochondrial DNA variants observed in Alzheimer disease and Parkinson disease patients. , 1993, Genomics.
[77] C. Filley,et al. Cytochrome oxidase deficiency in Alzheimer's disease , 1990, Neurology.
[78] M. Hanna,et al. Is the mitochondrial complex I ND5 gene a hot‐spot for MELAS causing mutations? , 2003, Annals of neurology.
[79] A. Torroni,et al. Mitochondrial oxidative phosphorylation defects in parkinson's disease , 1991, Annals of neurology.
[80] S. Lewin,et al. Quantification of mitochondrial DNA in peripheral blood mononuclear cells and subcutaneous fat using real-time polymerase chain reaction. , 2001, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[81] P. Mir,et al. Mitochondrial DNA A4336G Mutation in Alzheimer’s and Parkinson’s Diseases , 2002, European Neurology.
[82] H. Reichmann,et al. Unaltered respiratory chain enzyme activity and mitochondrial DNA in skeletal muscle from patients with idiopathic Parkinson's syndrome. , 1994, European neurology.
[83] D. Wallace,et al. Mitochondrial DNA sequence analysis of four Alzheimer's and Parkinson's disease patients. , 1996, American journal of medical genetics.